FLEXASO

Welcome to the Brand page for “FLEXASO”, which is offered here for Pharmaceutical research and development; research and development of pharmaceuticals and therapeutics to treat genetic and neurodegenerative diseases; research and development of pharmaceuticals and therapeutics which target the dna of specific disease-related proteins and regulate the protein's amount and countering the diseased pathway; research and development of pharmaceuticals and therapeutics which target the rna of specific disease-related proteins and regulate the protein's amount and countering the diseased pathway;.

Its status is currently believed to be active. Its class is unavailable. “FLEXASO” is believed to be currently owned by “QurAlis Corporation”.